Palti Yoram 4
4 · NovoCure Ltd · Filed Jul 18, 2018
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Palti Yoram
DirectorChief Technology Officer
Transactions
- Sale
Ordinary Shares
2018-07-16−27,685→ 1,071,054 total(indirect: Bennett Limited) - Sale
Ordinary Shares
2018-07-16−2,315→ 1,098,739 total(indirect: Bennett Limited)
Footnotes (3)
- [F1]On July 16, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 2,315 shares in multiple trades at prices ranging from $36.00 to $36.35. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]Professor Palti shares voting and investment power for the shares held by Bennett Limited.
- [F3]On July 16, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 27,685 shares in multiple trades at prices ranging from $35.00 to $35.95. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.